NovaBridge Biosciences (NBP) Goodwill (2018 - 2023)

NovaBridge Biosciences (NBP) has 6 years of Goodwill data on file, last reported at $22.4 million in Q2 2023.

• Quarterly Goodwill fell 7.63% year-over-year to $22.4 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $22.4 million (down 7.63% YoY) and the FY2022 annual result came in at $23.6 billion, up 92295.44% from the prior year.
• Goodwill retreated to $22.4 million in Q2 2023 per NBP's latest filing, from $22.9 million in the prior quarter.
• Across five years, Goodwill topped out at $25.4 billion in Q4 2021 and bottomed at $22.4 million in Q2 2023.
• The 5-year median for Goodwill is $23.9 million (2020), against an average of $2.8 billion.
• The widest annual swing landed in 2021, when Goodwill surged 103555.76%; it then slumped 99.91% in 2022.
• Tracing NBP's Goodwill over 5 years: stood at $23.1 million in 2019, then increased by 6.35% to $24.5 million in 2020, then surged by 103555.76% to $25.4 billion in 2021, then tumbled by 99.91% to $22.9 million in 2022, then fell by 1.92% to $22.4 million in 2023.
• Per Business Quant, the three latest NBP Goodwill figures stand at $22.4 million (Q2 2023), $22.9 million (Q4 2022), and $24.3 million (Q2 2022).

Peer Comparison